- Advanced search
- Immuno Portal
- Malaria Portal
Antibiotic DB is the first free, open-access database of antibacterial compounds, including discontinued agents, drugs under pre-clinical development and those in clinical trials. GtoPdb and Antibiotic DB are collaborating to help improve antibiotic compound coverage in GtoPdb, and to provide reciprocal links between the two resources. From April 2022 onwards, this collaboration has been supported by the Global Antibiotic Research and Development Partnership (GARDP), a not-for-profit organization developing new treatments for drug-resistant infections that pose the greatest threat to health.
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.✖
Tocris Bioscience is your trusted supplier of high-performance life science reagents, including receptor agonists & antagonists, enzyme inhibitors, ion channel modulators, fluorescent probes & dyes, and compound libraries.
The Tocris catalog consists of over 4,500 research tools for life science research, from industry standards to the latest and most innovative chemical tool compounds available. Our product range covers over 400 protein targets, enabling you to modulate the activity of numerous signaling pathways and physiological processes.
Trust Tocris for exceptional quality, consistent resupply, rapid delivery and an innovative stream of innovative new products.
We thank past major NC-IUPHAR/IUPHAR-DB sponsors UNESCO and Incyte, the ASPET Neuropharmacology Division for their support to NC-IUPHAR in 2011 and 2012, and past sponsors GlaxoSmithKline, Pfizer, Actelion, AstraZeneca and DiscoveRx.